Search
for
Sort by
Research 61–90 of 480
- Multicentric Reticulohistiocytosis Induced Alopecia: A Clinical Case Report
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Drug related lipid metabolism abnormalities: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS)
- Caractérisation des Réactions Paradoxales Psoriasiformes Alopéciantes Induites par les Anti-TNFα chez des Patients Atteints de Maladies Inflammatoires Chroniques de l’Intestin
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Evaluation of Effectiveness of Bio-Micro Injection in Treating Alopecia Universalis: A Non-Randomized Interventional Study
- LB922 CyTOF immune profiling uncovers sex- and race-specific differences and cellular biomarkers for biologic response in Hidradenitis suppurativa
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Farmácia Beleza, Matosinhos e Serviços Farmacêuticos do Cittadella Hospital - ULSS 6 Euganea, Itália
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- Genital Dermatology
- Psoriatic Alopecia in a Patient With Crohn Disease: An Uncommon Manifestation of Tumor Necrosis Factor α Inhibitors
- https://researchopenworld.com/genetics-of-hidradenitis-suppurativa/#
- Cells to Surgery Quiz: April 2020
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Quoi de neuf en dermatologie pédiatrique ?
- Immune signatures of psoriasis: Comparison of genetic expression profiles in psoriasis patients after therapy with biologic agents
- Contents
- PSS33 REAL-LIFE DOSING OF BIOLOGICS IN PLAQUE PSORIASIS—A GERMAN SURVEY
- Adverse Effects and Drug Interactions of Biologic Agents
- Importance of a multi-tiered treatment approach for intellectually and developmentally disabled patients with hidradenitis suppurativa
- Importance of a multi-tiered treatment approach for intellectually and developmentally disabled patients with hidradenitis suppurativa
- LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- The most recent advances in understanding and managing hidradenitis suppurativa
- Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system